224 related articles for article (PubMed ID: 30282073)
1. Divergent Effects of Cyclophilin-D Inhibition on the Female Rat Heart: Acute Versus Chronic Post-Myocardial Infarction.
Parodi-Rullán RM; Soto-Prado J; Vega-Lugo J; Chapa-Dubocq X; Díaz-Cordero SI; Javadov S
Cell Physiol Biochem; 2018; 50(1):288-303. PubMed ID: 30282073
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure.
Lim SY; Hausenloy DJ; Arjun S; Price AN; Davidson SM; Lythgoe MF; Yellon DM
J Cell Mol Med; 2011 Nov; 15(11):2443-51. PubMed ID: 21143389
[TBL] [Abstract][Full Text] [Related]
3. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.
Clarke SJ; McStay GP; Halestrap AP
J Biol Chem; 2002 Sep; 277(38):34793-9. PubMed ID: 12095984
[TBL] [Abstract][Full Text] [Related]
4. Elucidating Mitochondrial Electron Transport Chain Supercomplexes in the Heart During Ischemia-Reperfusion.
Jang S; Lewis TS; Powers C; Khuchua Z; Baines CP; Wipf P; Javadov S
Antioxid Redox Signal; 2017 Jul; 27(1):57-69. PubMed ID: 27604998
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection?
Javadov S; Jang S; Parodi-Rullán R; Khuchua Z; Kuznetsov AV
Cell Mol Life Sci; 2017 Aug; 74(15):2795-2813. PubMed ID: 28378042
[TBL] [Abstract][Full Text] [Related]
6. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.
Lim SY; Davidson SM; Hausenloy DJ; Yellon DM
Cardiovasc Res; 2007 Aug; 75(3):530-5. PubMed ID: 17512507
[TBL] [Abstract][Full Text] [Related]
7. Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy.
Matas J; Young NT; Bourcier-Lucas C; Ascah A; Marcil M; Deschepper CF; Burelle Y
J Mol Cell Cardiol; 2009 Mar; 46(3):420-30. PubMed ID: 19094991
[TBL] [Abstract][Full Text] [Related]
8. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.
Javadov SA; Clarke S; Das M; Griffiths EJ; Lim KH; Halestrap AP
J Physiol; 2003 Jun; 549(Pt 2):513-24. PubMed ID: 12692185
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection.
Bell RM; Kunuthur SP; Hendry C; Bruce-Hickman D; Davidson S; Yellon DM
Basic Res Cardiol; 2013 Mar; 108(2):331. PubMed ID: 23361433
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of idebenone do not involve ROS scavenging: Evidence for mitochondrial complex I bypass in ischemia/reperfusion injury.
Perry JB; Davis GN; Allen ME; Makrecka-Kuka M; Dambrova M; Grange RW; Shaikh SR; Brown DA
J Mol Cell Cardiol; 2019 Oct; 135():160-171. PubMed ID: 31445917
[TBL] [Abstract][Full Text] [Related]
11. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
Hausenloy D; Wynne A; Duchen M; Yellon D
Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Hyperacetylation in the Failing Hearts of Obese Patients Mediated Partly by a Reduction in SIRT3: The Involvement of the Mitochondrial Permeability Transition Pore.
Castillo EC; Morales JA; Chapoy-Villanueva H; Silva-Platas C; Treviño-Saldaña N; Guerrero-Beltrán CE; Bernal-Ramírez J; Torres-Quintanilla A; García N; Youker K; Torre-Amione G; García-Rivas G
Cell Physiol Biochem; 2019; 53(3):465-479. PubMed ID: 31464387
[TBL] [Abstract][Full Text] [Related]
13. HAX-1 regulates cyclophilin-D levels and mitochondria permeability transition pore in the heart.
Lam CK; Zhao W; Liu GS; Cai WF; Gardner G; Adly G; Kranias EG
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6466-75. PubMed ID: 26553996
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion.
Boengler K; Hilfiker-Kleiner D; Heusch G; Schulz R
Basic Res Cardiol; 2010 Nov; 105(6):771-85. PubMed ID: 20960209
[TBL] [Abstract][Full Text] [Related]
15. Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy.
Feng Y; Madungwe NB; da Cruz Junho CV; Bopassa JC
Br J Pharmacol; 2017 Dec; 174(23):4329-4344. PubMed ID: 28906548
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury.
Hausenloy DJ; Duchen MR; Yellon DM
Cardiovasc Res; 2003 Dec; 60(3):617-25. PubMed ID: 14659807
[TBL] [Abstract][Full Text] [Related]
17. Fast therapeutic hypothermia prevents post-cardiac arrest syndrome through cyclophilin D-mediated mitochondrial permeability transition inhibition.
Jahandiez V; Cour M; Bochaton T; Abrial M; Loufouat J; Gharib A; Varennes A; Ovize M; Argaud L
Basic Res Cardiol; 2017 Jul; 112(4):35. PubMed ID: 28492973
[TBL] [Abstract][Full Text] [Related]
18. The mitochondrial permeability transition pore and cyclophilin D in cardioprotection.
Di Lisa F; Carpi A; Giorgio V; Bernardi P
Biochim Biophys Acta; 2011 Jul; 1813(7):1316-22. PubMed ID: 21295622
[TBL] [Abstract][Full Text] [Related]
19. A novel fission-independent role of dynamin-related protein 1 in cardiac mitochondrial respiration.
Zhang H; Wang P; Bisetto S; Yoon Y; Chen Q; Sheu SS; Wang W
Cardiovasc Res; 2017 Feb; 113(2):160-170. PubMed ID: 27794519
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
